Cover Image

Down-regulation of ABCC11 protein (MRP8) in human breast cancer

Aim of this article is to investigate the expression of ABCC11 (MRP8) protein in normal breast tissue, and examine the difference in ABCC11 mRNA and protein expression between normal breast and breast cancer tissues taking into account ABCC11 genotype (a functional SNP, rs17822931) and estrogen rece...

Full description

Saved in:

Bibliographic Details
Published in:	Experimental Oncology
Date:	2011
Main Authors:	Sosonkina, N., Nakashima, M., Ohta, T., Niikawa, N., Starenki, D.
Format:	Article
Language:	English
Published:	Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2011
Subjects:	Original contributions
Online Access:	https://nasplib.isofts.kiev.ua/handle/123456789/32317
Tags:	Add Tag No Tags, Be the first to tag this record!
Journal Title:	Digital Library of Periodicals of National Academy of Sciences of Ukraine
Cite this:	Down-regulation of ABCC11 protein (MRP8) in human breast cancer / N. Sosonkina, M. Nakashima, T. Ohta, N. Niikawa, D. Starenki // Experimental Oncology. — 2011. — Т. 33, № 1. — С. 42–46. — Біліогр.: 22 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine

Similar Items

Genetic polymorphisms of the renin-angiotensin system in breast cancer patients
by: Fishchuk, L.E., et al.
Published: (2013)

Are CD44⁺/CD24⁻ cells the assumed cancer stem cells in breast cancer?
by: Ryspayeva, D.E., et al.
Published: (2017)

Dihydropyrimidine dehydrogenase activity correlates with fluorouracil sensitivity in breast cancer
by: Yu, Z., et al.
Published: (2007)

Aspisol inhibits tumor growth and induces apoptosis in breast cancer
by: Zhu, X.G., et al.
Published: (2008)

Clinicopathological features of nonspecific invasive breast cancer according to its molecular subtypes
by: Zavyalova, M., et al.
Published: (2016)

Breast cancer immunohistochemical features in young women with BRCA1/2 mutations
by: Zakhartseva, L.M., et al.
Published: (2009)

The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
by: Todor, I.N., et al.
Published: (2012)

Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
by: Chekhun, S.V., et al.
Published: (2014)

Distribution and accumulation of liposomal form of doxorubicin in breast cancer cells of MCF-7 line
by: Rusetskaya, N.V., et al.
Published: (2011)

OX40L gene polymorphism and breast cancer in Iranian population
by: Vakil Monfared, R., et al.
Published: (2018)

The role of cardiac biomarkers as predictors of trastuzumab cardiotoxicity in patients with breast cancer
by: Ürün, Y., et al.
Published: (2015)

Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells
by: Chekhun, V.F., et al.
Published: (2015)

Characteristics of homocysteine-induced multidrug resistance of human MCF-7 breast cancer cells and human A2780 ovarian cancer cells
by: Lukyanova, N.Yu.
Published: (2010)

Cytogenetic effects of neutron therapy in patients with parotid gland tumors and relapse of breast cancer
by: Melnikov, A.A., et al.
Published: (2012)

Impact of stromal cell components of tumor microenvironment on epithelial-mesenchymal transition in breast cancer cells
by: Bezdenezhnykh, N., et al.
Published: (2014)

Artemisinin modulating effect on human breast cancer cell lines with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2017)

Lactoferrin expression in breast cancer in relation to biologic properties of tumors and clinical features of disease
by: Naleskina, L.A., et al.
Published: (2016)

Clinical and immunohistochemical features of primary breast cancer and metachronous ovarian and endometrial tumors
by: Kryzhanivska, A.E., et al.
Published: (2018)

СD44+/CD24− markers of cancer stem cells in patients with breast cancer of different molecular subtypes
by: Chekhun, S.V., et al.
Published: (2015)

Effect of 5-azacytidine on mirna expression in human breast cancer cells with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2016)

Lapatinib-based therapy for women with advanced/metastatic HER2 positive breast cancer
by: Zekri, J., et al.
Published: (2015)

Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
by: Chekhun, S., et al.
Published: (2013)

Establishment and characterization of new breast and ovarian cancer cell lines as a model for studying cellular plasticity in vitro
by: Bezdieniezhnykh, N., et al.
Published: (2016)

Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
by: Yalovenko, T.M., et al.
Published: (2016)

Correlation of iodine symporter expression in highly and low malignant cell lines of human breast cancer differed in their sensitivity to doxorubicin
by: Lukianova, N.Yu., et al.
Published: (2016)

High body-mass index is not associated with worse clinicopathological characteristics in predominantly obese breast cancer patients
by: Kemal, Y., et al.
Published: (2015)

Genotoxic factors associated with the development of receptor-negative breast cancer: potential role of the phenomenon of switching of estrogen effects
by: Berstein, L.M., et al.
Published: (2006)

Establishment of serum protein pattern for screening colorectal cancer using SELDI-TOF-MS
by: Zheng, G.X., et al.
Published: (2006)

Association of polymorphic G1934A variant (allele *4) of CYP2D6 gene with increased risk of breast cancer development in Ukrainian women
by: Levkovich, N.N., et al.
Published: (2011)

Down regulation of u-PA by a nutrient mixture in hemangioma (EOMA) cells by inducing caspase-dependent apoptosis
by: Roomi, M.W., et al.
Published: (2018)

Influence of exogenous lactoferrin on the oxidant/ antioxidant balance and molecular profile of hormone receptor-positive and -negative human breast cancer cells in vitro
by: Zalutski, I.V., et al.
Published: (2017)

Impact of combinations of EGF, TGFβ, 17β-oestradiol, and inhibitors of corresponding pathways on proliferation of breast cancer cell lines
by: Mints, M., et al.
Published: (2014)

The level of IgG antibodies reactive to TF, Tn and Alpha-Gal polyacrylamide-glycoconjugates in breast cancer patients: relation to survival
by: Smorodin, E.P., et al.
Published: (2016)

Relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer
by: Timovska, Yu.O., et al.
Published: (2009)

Ukrain, a plant derived semi-synthetic compound, exerts antitumor effects against murine and human breast cancer and induce protective antitumor immunity in mice
by: Bozeman, E.N., et al.
Published: (2012)

Relationship between NF-κB, ER, PR, Her2/neu, Ki67, p53 expression in human breast cancer
by: Shapochka, D.O., et al.
Published: (2012)

Intensive cyclic chemotherapy and transplantation of autologous peripheral blood progenitor cells (PBPC) or whole blood in high-risk breast cancer — follow up at 10 years
by: Cinek, P., et al.
Published: (2007)

Effects of low and high concentrations of antitumour drug taxol in anaplastic thyroid cancer cells
by: Pushkarev, V.M., et al.
Published: (2009)

CD8 and CD45RO T lymphocytes in bone marrow of gastric cancer patients: correlation with disseminated tumor cells and disease outcome
by: Osinsky, S., et al.
Published: (2015)

Kinase suppressor of Ras 2 is involved in regulation of cell proliferation and is up-regulated in human invasive ductal carcinomas of breast
by: Jia, M., et al.
Published: (2010)